China 10-Methoxy Iminostilbene market continued to move up in October, following the upward trend in September. September’s gains were supported by rising cost, stable pharma offtake and stable currency, which prompted producers to keep the price up. In October, supply was steady, producers ran smoothly and no disruption, exporters adjusted offers according to cost pressure and robust demand from overseas. End-user consumption in pharma, cosmetics and personal care increased visibly, driven by the increase of Carbamazepine synthesis and health sector. Market participants noted international customers are buying ahead as trade condition stabilized and inventory aligned with consumption pattern. For November 2025, sentiment is still firm. Seasonal procurement and restocking from both domestic and export buyers will tighten the spot supply. With production running smoothly, 10-Methoxy Iminostilbene will continue to move up in November.
